Probiotic Use for Recovery Enhancement From Long COVID-19

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

July 31, 2026

Conditions

Post-Acute COVID-19 Syndrome

Interventions

DRUG

Probiotic Agent

BlueBiology: Ultimate Care probiotic pill taken once daily for a four-month period.

OTHER

Placebo

Placebo produced to be identical in taste and appearance to the probiotic agent, taken once daily for a four-month period.

Trial Locations (1)

Rush University Medical Center, Chicago

All Listed Sponsors

lead

Rush University Medical Center

OTHER

NCT06643299 - Probiotic Use for Recovery Enhancement From Long COVID-19 | Biotech Hunter | Biotech Hunter